Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Near-term risk sidelines UBS on Polaris

Published 01/27/2023, 07:20 AM
Updated 01/27/2023, 07:31 AM
© Reuters.  Near-term risk sidelines UBS on Polaris (PII)

By Michael Elkins

UBS downgraded Polaris (NYSE:PII) to a Neutral rating (From Buy) and cut the stock’s price target to $112.00 (from $165.00), driven by lower ORV shipment estimates, and a slightly lower gross margin as a result of near-term retail disappointment and risk for market share loss for PII.

UBS analysts wrote in a note, “We see risk to guidance that retail sales would be positive in Q4. We also believe that the top-line opportunity of restocking the channel will be mostly behind after Q1, as our dealer checks indicate much better inventory availability in the dealer network outside of a few of the higher-end SSV models. Additionally, we believe PII must work to defend its market share over the next several quarters given competitiveness from not only BRP’s production growth, but also from smaller OEMs that compete on price. While investor sentiment heading into Q4 results has been bearish and may therefore see a covering rally after results, our rating change goes beyond just Q4 results.”

Last week, a UBS dealer panel had Polaris retail range from down to flat to up, since they all had different bases depending on when they got inventory in the prior year. However, broader preliminary channel checks outside of just the dealer panel suggested that Polaris may not have had the positive retail for Q4 that it initially indicated. Overall industry ORV demand, according to the checks, continues from the consumer, with the usual seasonal slowdown, but dealers anticipate near-term ORV sales will remain at levels well above pre-pandemic.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

UBS’ 2023 revenue estimate for the company is unchanged at $8.77 billion, above consensus of $8.43B, and 2023 ORV revenue growth estimate also remains unchanged at +2% YOY. Gross margin estimates are unchanged at 23.7% (vs. Street's 23.4%) though UBS lowered operating margin estimates to 9.3% from 10.3%. As a result, 2023 EPS estimates move to $9.98 from $11.17 prior, in line with consensus of $9.92.

Shares of PII are down 1.84% in premarket trading on Friday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.